Compound 264
Identifiers
- Canonical SMILES:
Cc1cccc(Cl)c1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O
- IUPAC name:
(2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid
- InChi:
InChI=1S/C19H17ClN2O3/c1-11-5-4-7-14(20)17(11)18(23)22-16(19(24)25)9-12-10-21-15-8-3-2-6-13(12)15/h2-8,10,16,21H,9H2,1H3,(H,22,23)(H,24,25)/t16-/m0/s1
- InChiKey:
PMUGSFJFKNRORH-INIZCTEOSA-N
External links
44305149 |
CHEMBL62651 |
23156050 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.19 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 356.09 g/mol | |||
HBA | 5 | |||
HBD | 3 | |||
HBA + HBD | 8 | |||
AlogP | 3.97 | |||
TPSA | 82.19 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6906 | Golotimod | DB05475 | |
0.6857 | Rebamipide | DB11656 | |
0.6693 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.6667 | Oglufanide | DB05779 | |
0.6518 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.6349 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.6233 | Gramicidin D | DB00027 | |
0.6230 | D-Tryptophan | DB03225 | |
0.6230 | Tryptophan | DB00150 | |
0.6220 | Beta-Hydroxytryptophane | DB04159 | |
0.6172 | Oxitriptan | DB02959 | |
0.6159 | (2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid | DB03605 | |
0.5962 | Somatoprim | DB12777 | |
0.5923 | Indoximod | DB12827 | |
0.5909 | 5-fluorotryptophan | DB03314 |